In prostate cancer care, electronic health (eHealth) and mHealth interventions have helped patients understand their disease severity, weigh the risks and benefits of various treatment options, and track key information such as prostate-specific antigen (PSA) laboratory results [16]. The gene discussed is KLK3; the disease is prostate carcinoma.